Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Share-based Compensation: 2018-2025

Historic Share-based Compensation for Zai Lab (ZLAB) over the last 6 years, with Sep 2025 value amounting to $16.9 million.

  • Zai Lab's Share-based Compensation rose 0.76% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.9 million, marking a year-over-year decrease of 9.41%. This contributed to the annual value of $70.7 million for FY2024, which is 11.28% down from last year.
  • Latest data reveals that Zai Lab reported Share-based Compensation of $16.9 million as of Q3 2025, which was down 0.29% from $17.0 million recorded in Q2 2025.
  • Zai Lab's 5-year Share-based Compensation high stood at $22.0 million for Q3 2023, and its period low was $7.3 million during Q1 2021.
  • Its 3-year average for Share-based Compensation is $18.2 million, with a median of $17.2 million in 2024.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 184.93% in 2021, then declined by 23.63% in 2024.
  • Over the past 5 years, Zai Lab's Share-based Compensation (Quarterly) stood at $12.6 million in 2021, then increased by 23.41% to $15.6 million in 2022, then surged by 31.56% to $20.5 million in 2023, then dropped by 15.79% to $17.2 million in 2024, then increased by 0.76% to $16.9 million in 2025.
  • Its last three reported values are $16.9 million in Q3 2025, $17.0 million for Q2 2025, and $15.8 million during Q1 2025.